Cyclerion Therapeutics, Inc. (CYCN) earnings
CYCN earnings moved a median of +2.43% by the close. Quarterly and annual CYCN reports and results, each read against the price at its own news timestamp. Back to the CYCN overview →
13 measured CYCN earnings events.
Where these CYCN earnings landedvs 11 measured CYCN earnings reactions
| Middle 50% of CYCN earnings reactions | +1.02% to +5.12% |
|---|---|
| Median reaction (to close) | +2.43% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 CYCN earnings events with a measured close landed between +1.02% and +5.12%; 82% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Cyclerion Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +1.43% | |
| Form 10-Q Cyclerion Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.46% | +1.62% | |
| Form 10-K/A Cyclerion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.22% | +0.61% | |
| Form 10-K Cyclerion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | +6.16% | |
| Form 10-K/A Cyclerion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.50% | — | |
| Form 10-Q Cyclerion Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.50% | — | |
| Form 10-Q Cyclerion Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.89% | -11.48% | |
| Form 10-Q Cyclerion Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.48% | +12.83% | |
| Form 10-K Cyclerion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -4.56% | -7.99% | |
| Form 10-Q Cyclerion Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.70% | +45.76% | |
| Form 10-Q Cyclerion Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | +4.07% | |
| Form 10-Q Cyclerion Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +2.43% | |
| Form 10-K Cyclerion Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | +3.70% |
Keep exploring
More CYCN: analyst actions → · SEC filings → · CYCN overview →